Effects of Salvia przewalskii Maxim. on high-altitude pulmonary hypertension in rats and its mechanism

doi:10.12047/j.cjap.5854.2019.117

Abstract

Abstract: Objective: To investigate the interventive effects of Salvia przewalskii Maxim.(SPM)on high-altitude pulmonary hypertension(HAPH)in rats and possible mechanism. Methods: The male SD rats were randomly divided into the control group, the hypoxia group and SPM(0.5 g/kg,1 g/kg and 2 g/kg) group. There were 14 rats in each group. The rats in control group were feed in Xining(with an altitude about 2 260 m), and the other group rats were all feed in Maduo county people’s hospital(with an altitude about 4 260 m). The rats in SPM groups were treated with SPM at the doses of 0.5 g/kg,1 g/kg and 2 g/kg by gavage respectively (100 g/ml). The rats in control and the hypoxia groups were received equal volume of distilled water, once a day. After 4 weeks, the mean pulmonary artery pressure (mPAP) of rats was measured and the same part of lung tissue of each rat was collected and stored in liquid nitrogen. Then the relative mRNA expression levels of the proliferation cell nuclear antigen(PCNA), the cell cycle dependent kinase 4(CDK4), CyclinD1, RhoA, ROCK1, ROCK2 in lung tissues of each group rats were all tested by RT-PCR. Results: Compared with the control group, the mPAP and the relative mRNA expression levels of PCNA, CDK4, CyclinD1, RhoA, ROCK1 and ROCK2 were increased significantly in the hypoxia group(P＜0.01). Compared with the hypoxia group, the mPAP and the relative mRNA expression levels of PCNA, CDK4, CyclinD1, RhoA, ROCK1 and ROCK2 in the lung tissues of the SPM group rats were all decreased significantly(P＜ 0.05 or P＜0.01). Conclusion: SPM can prevent the HAPH in rats, and the mechanisms may be related to the inhibition of the excessive proliferation of smooth muscle cells in pulmonary artery and the excessive activation of the RhoA/Rho kinase(ROCK) signaling pathway.

Key words: Salvia przewalskii Maxim, rats, high-altitude, pulmonary hypertension

CLC Number:

285.5

WANG Ya-feng, WANG Ai-xia, WANG Sheng-biao, DUO De-long, LI Qian, YAN Ying-jun. Effects of Salvia przewalskii Maxim. on high-altitude pulmonary hypertension in rats and its mechanism[J]. CJAP, 2019, 35(6): 533-536.

References

[1] Chen M, Shen H, Zhu L, et al. Berberine attenuates hypoxia-induced pulmonary arterial hypertension via bone morphogenetic protein and transforming growth factor-β signaling[J]. J Cell Physiol, 2019, 234(10): 1-12.
[2] Wu F, Yao W, Yang J, et al. Protective effects of aloperin on monocroline-induced pulmonary hypertension via regulation of Rho A/Rho kinsase pathway in rats[J]. Biomed Pharmacother, 2017, 95: 1161-1168.
[3] 翁裕馨, 刘占厚, 陈湘宏. 青海省甘西鼠尾草的生药学研究[J]. 药学研究, 2015, 34(3): 144-146.
[4] 王利彦, 王津慧, 吕慧玲, 等. 甘西鼠尾草的抗缺氧研究[J]. 四川中医, 2009, 27(4): 43-44.
[5] Nan X, Su S, Ma K, et al. Bioactive fraction of Rhodiola algida against chronic hypoxia-induced pulmonary arterial hypertension and its anti-proliferation mechanism in rats[J]. J Ethnopharmacol, 2018, 216: 175-183.
[6] 崔建华, 高亮, 张东祥, 等. 埃他卡林对低氧性肺动脉高压患者某些血清酶活性及自由基代谢的影响[J]. 中国应用生理学杂志, 2012, 28(5): 385-388.
[7] Galiè N, Hoeper MM, Humbert M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: the task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)[J]. Eur Heart J, 2009, 30(20): 2493-2537.
[8] Xu D, Li Y, Zhang B, et al. Resveratrol alleviate hypoxic pulmonary hypertension via anti-inflammation and anti-oxidant pathways in rats[J]. Int J Med Sci, 2016, 13(12): 942.
[9] 张聪聪, 张晶晶, 陈俊豪, 等. 益气温阳活血化痰方对低氧高二氧化碳性肺动脉高压的作用及其机制[J]. 中国应用生理学杂志, 2018, 34(5): 408-413.
[10]许益笑, 王园园, 贾旭广, 等. 内源性硫化氢体系与低O₂高CO₂性肺动脉高压的相关性研究[J]. 中国应用生理学杂志, 2011, 27(3): 300-304.
[11]Li Y, Shi B, Huang L, et al. Suppression of the expression of hypoxia-inducible factor-1α by RNA interference alleviates hypoxia-induced pulmonary hypertension in adult rats[J]. Int J Mole Med, 2016, 38(6): 1786-1794.
[12]孟涵燕, 赵洁, 花春艳, 等. 苹果多酚通过下调钙敏感受体改善大鼠低氧性肺动脉高压的作用[J]. 中国应用生理学杂志, 2018, 34(3): 242-246.
[13]Lan B,Hayama E, Kawaguchi N, et al. Therapeutic efficacy of valproic acid in a combined monocrotaline and chronic hypoxia rat model of severe pulmonary hypertension[J]. PloS One, 2015, 10(1): e0117211.
[14]Zhang S, Wang M, Li Q, et al. MiR-101 reduces cell proliferation and invasion and enhances apoptosis in endometrial cancer via regulating PI3K/Akt/mTOR[J]. Cancer Biomark, 2017, 21(1): 179-186.
[15]He Q, Nan X, Li S, et al. Tsantan sumtang alleviates chronic hypoxia-induced pulmonary hypertension by inhibiting proliferation of pulmonary vascular cells[J]. BioMed Res Int, 2018, 2018: 9504158.
[16]Ishikura K, Yamada N, Ito M, et al. Beneficial acute effects of rho-kinase inhibitor in patients with pulmonary arterial hypertension[J]. Circ J, 2006, 70(2): 174-178.
[17]Fukumoto Y, Takaki A, Tawara S, et al. Evidence for Rho-kinase activation in patients with pulmonary arterial hypertension[J]. Circ J, 2009, 73(9): 1731-1739.
[18]Lopez NC, Ebensperger G, Herrera EA, et al. Role of the RhoA/ROCK pathway in high-altitude associated neonatal pulmonary hypertension in lambs[J]. Am J Physiol Regul Integr Comp Physiol, 2016, 310(11): 1053-1063.
[19]Connolly MJ, Aaronson PI. Key role of the RhoA/Rho kinase system in pulmonary hypertension[J]. Pulm Pharmacol Ther, 2011, 24(1): 1-14.
[20]Elias-Al-Mamun M, Satoh K, Tanaka S, et al. Combination therapy with fasudil and sildenafil ameliorates monocrotaline-induced pulmonary hypertension and survival in rats[J]. Circ J, 2014, 78(4): 967-976.